Slingshot members are tracking this event:
Lilly's(LLY) Mirikizumab in Crohn's disease Phase 2 data due at DDW meeting 18-21 May, 2019
Slingshot Insights Explained
May 21, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Mirikizumab, Crohn's Disease, Phase 2 Clinical Trial Data